Effect of CYP3A5*3 and CYP3A4*18B Genetic Polymorphisms on Cyclosporine Pharmacokinetics in Renal Transplant Patients

胡永芳,翟所迪,邱雯

DOI: https://doi.org/10.3321/j.issn:1001-1978.2009.03.024

2009-01-01

Abstract:Aim To evaluate retrospectively the effect of genetic polymorphisms in CYP3A4 and CYP3A5 on cyclosporine pharmacokinetics during the early period in renal transplant patients.Methods Polymerase chain reaction-restriction fragment length polymorphism was performed to genotype for CYP3A4*18B and CYP3A5*3.Cyclosporine whole blood levels were measured by fluorescence polarization immunoassay.Results The frequencies of CYP3A4*18B and CYP3A5*3 variant alleles were 0.235(95 CI:0.235~ 0.241)and 0.770(95 CI:0.767~0.773),respectively in 63 of renal transplantation patients, and these alleles exhibited incomplete linkage disequilibrium. The median (range) value of cyclosporine dose adjusted blood trough concentrations (C0/D) and C0 in CYP3A4*1/*1 genotype patients was higher than that in CYP3A4*1/*18B and CYP3A*18B/*18B patients, the same result was found in CYP3A5 expression (CYP3A5*3/*1 and CYP3A5*1/*3) (P0.05, Mann-Whitney U test); cyclosporine dose in CYP3A5*1/*1 genotype patients were higher than that in CYP3A5*1/*3 or CYP3A5*3/*3 patients (P=0.0040.01,Kruakal-Wallis Test) in the first month after renal transplantation. In addition, no other statistically significant association was found between cyclosporine and CYP3A4*18B as well as CYP3A5*3 SNPs.Conclusions Genetic polymorphism of CYP3A5*3 and CYP3A4*18B may be partly responsible in large interindividual variability of cyclosporine pharmacokinetics after transplantation, but the test for CYP3A5*3 genotype before transplantation remains to be explained.